Severe hypertension and rapidly progressive acute renal failure is a well recognized complication of scleroderma, often referred to as the renal crisis, and widely thought to cause irreversible deterioration in renal function. With the advent of angiotensin-converting-enzyme inhibitors (ACE-I) the outlook for patients with this condition has dramatically improved. We report here one such patient.
CannonP.J., HassarM., CaseD.B., CasarellaW.J., SommersS.C., LeroyE.C.. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation.Medicine (Baltimore)1974; 53: 1–46
SteenV.D., MedsgerT.A., OsailT.A., ZeiglerG.L., ShapiroA.P., RodnanG.P.. Factors predicting development of renal involvement in progressive systemic sclerosis.Am J Med1984; 76: 779–86
4.
TraubY.M., ShapiroA.P., RodnanG.P.Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis: review of a 25-year experience with 68 cases.Medicine (Baltimore)1983; 62: 335–52
5.
SteenV.D., ConstantinoJ.P., ShapiroA.P., MedsgerT.A.. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors.Ann Intern Med1990; 113: 354–7
6.
GarvasH., GarvasI., CannonP.J., BrunnerH.R., LaraghJ.H.. Is elevated plasma renin activity of prognostic importance in systemic sclerosis (scleroderma)?Arch Int Med1977; 1371554–8
7.
Lopez-OverjeroJ., SaalS., D'AngeloW., CheighJ., StenzelK., LaraghJ.. Reversal of vascular and renal crisis of scleroderma by oral angiotensin-converting-enzyme blockage.V Engl J Med1979; 300: 1417–20
8.
ChapmanP.J., PascoeM.D., van Zyl-SmitR.. Successful use of Captopril in the treatment of scleroderma renal crisis.Clin Nephrol1986; 26: 106–8
9.
BrownE.A., MacGregorG.A., MainiR.N.. Failure of Captopril to reverse the crisis of scleroderma.Ann Rheum Dis1983; 42: 52–3
